Comparing a daily versus weekly titration algorithm in people with type 2 diabetes switching from basal insulin to iGlarLixi in the LixiLan ONE CAN randomized trial.

Irene Hramiak Ulagamadesan Venkatesan Lawrence Alan Leiter Jean-François Yale Harpreet S BajajJohn StewartMarie-Josée ToutounjiStewart B Harris

Published in: Diabetes, obesity & metabolism (2022)

A daily titration algorithm for switching basal insulin to iGlarLixi was shown to be non-inferior and superior for glycaemic control and weight compared with weekly titration.

Keyphrases

type diabetes
physical activity
machine learning
deep learning
glycemic control
body mass index
weight loss
neural network
insulin resistance
weight gain